A post by The Bitcoin Historian on Nov. 12 highlighted that Bitcoin's relative strength index (RSI) has crossed above 50, a level previously linked to new all-time highs. The account, citing Fidelity, described this RSI move as marking the end of the bear market and called the current dip temporary, suggesting it as a historic buying opportunity. However, no specific Fidelity representative or detailed research was named, and no exact dates or RSI readings for past crossings were provided. This signal is significant as RSI measures momentum, indicating potential upward price movement for Bitcoin.
The Bitcoin Historian's post on Bitcoin RSI is context for readers following cryptocurrency momentum. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 12, 2026 20:32 WIB: out of 50 priced major cryptocurrencies, 6 rose and 43 fell today. EOS (EOS.IO) gained 8.13% to Rp12.649, ENJ (Enjin Coin) dropped 8.24% to Rp388, and UNI (Uniswap) decreased 6.07% to Rp110.129 with a Pluang order activity of 75% Sell / 25% Buy.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
